GLP-1(9-36) and GLP-1(7-36) in the concentrations of 1, 10 and 100 nM showed statistically significant inhibition of cell growth in human adipose tissue derived stem cells (hASCs), without any dose-dependent effects
Ozempic is whats known as a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that also includes liraglutide (Victoza), dulaglutide (Trulicity), and exenatide (Bydureon)
The proportion of psychiatric AEs reported as adverse reactions in patients treated with semaglutide (5.82%) was slightly higher than that in patients treated with other GLP-1 RAs
Instruct patients to seek medical advice if severe joint pain occurs [see Warnings and Precautions (5.6)]
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, et al